Wearable Injectors Market

Wearable Injectors Market by Applications (Cardiovascular Diseases, Autoimmune Diseases, Oncology, Infectious Diseases, and Others), Types (Off-body and On-body), Technology (Expanding Battery, Motor-driven, Spring-based, Rotary Pump, and Others), End-users (Clinics, Home Care, Hospitals, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3696
  • Author: Growth Market Reports
  • Rating: 4.7
  • Total Reviews: 3
  • No. Of Pages: 211
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global wearable injectors market size was valued at USD 4.85 billion in 2020 and is projected to reach USD 18.27 billion by 2028, expanding at a CAGR of 17 % during the forecast period, 2021–2028. The growth of the market is attributed to the rising prevalence of chronic diseases, such as diabetes, cardiovascular disease, and cancer globally.


Wearable Injectors Market key takeaways

Wearable injectors are medication delivery systems that monitor the human body and provide significant amounts of pharmaceuticals subcutaneously over time. Recent advancements in biotechnology have resulted in the production of a wide spectrum of protein-based compounds that must be injected in order to achieve improved therapeutic effects. Key suppliers are working on creating big volume wearable injectors devices to satisfy the volume constraints of current intramuscular and subcutaneous administration systems.
The COVID-19 pandemic outbreak had positive impact on the market. During the pandemic, there has been a shift in medical priorities among healthcare organizations, with the treatment of COVID-19 patients taking precedence. This resulted in the growth of the wearable injectors market.

Market Trends, Drivers, Restraints, and Opportunities

  • Shift of healthcare delivery toward homecare is one of the key factors driving the market growth.
  • Growing demand of convenient methods of drug administration is expected to boost the market growth in the coming years.
  • Stringent government regulation for product approval presents a major challenge. This is likely to hinder the market growth during the forecast period.
  • Rising preference for traditional methods of drug delivery is expected to hamper the market growth during the projected timeline.
  • Increasing demand for biologics and monoclonal antibody is projected to create significant growth opportunities for the market in the near future.

Scope of the Report

The report on the global wearable injectors market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Wearable Injectors Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Cardiovascular Diseases, Autoimmune Diseases, Oncology, Infectious Diseases, and Others), Types (Off-body and On-body), Technology (Expanding Battery, Motor-driven, Spring-based, Rotary Pump, and Others), and End-users (Clinics, Home Care, Hospitals, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

CeQur SA; West Pharmaceutical Services, Inc.; Becton, Dickinson and Company; F. Hoffmann-La Roche AG; Unilife Corp.; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet Corp.; Enable Injections, Inc.; and Johnson & Johnson Pvt. Ltd.

Market Segment Insights

Oncology segment to grow at a rapid pace

Based on applications, the global wearable injectors market is divided into cardiovascular diseases, autoimmune diseases, oncology, infectious diseases, and others. The oncology segment is expected to grow at a rapid pace during the forecast period owing to the increased incidence of cancer, combined with a growing trend among patients to self-administer medication. However, the autoimmune diseases segment is anticipated to hold a key share of the market in the coming years due to their competitive advantage over insulin pumps, the rising prevalence of diabetes, and the increasing acceptance of wearable injectors.


Wearable Injectors Market By Applications

On-body segment to expand at a considerable CAGR

On the basis of types, the market is bifurcated into off-body and on-body. The on-body segment is projected to expand at a considerable CAGR during the forecast period attributed to the properties, such as being water-resistant, convenient to use at home, and comfortable to put on the skin particularly the stomach. On the other hand, the off-body segment is anticipated to account for a major market share during the forecast period as these devices remove risks including painful device removal, skin adhesive fitting difficulties, and skin sensitivity or irritation.

Spring-based segment to hold significant market share

In terms of technology, the global wearable injectors market is segmented into expanding battery, motor-driven, spring-based, rotary pump, and others. The spring-based segment is anticipated to hold significant market share in the coming years owing to the increasing prevalence of adhesive patches, which are easy to apply and allow patients to inject drugs subcutaneously by pressing one or more buttons on the device. However, the motor-driven segment is expected to register a considerable CAGR during the forecast period due to growing customer need for motor-driven devices as these are considerably convenient in use when compared with other devices.


Wearable Injectors Market By Technology

Home care to expand at robust growth rate

On the basis of end-users, the market is segregated into clinics, home care, hospitals, and others. The home care segment is estimated to expand at robust growth rate during the forecast period attributed to the increasing need to curb healthcare costs and rising preference for self-administration of medication. On the other hand, the hospitals segment is expected to grow at a significant rate due to the increasing number of hospitals across the globe.

North America to constitute a key market share

In terms of regions, the global wearable injectors market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to the rising prevalence of lifestyle-related and chronic diseases and the presence of sophisticated healthcare infrastructure in the region. However, the market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period attributed to the wide diabetic population, increasing geriatric population, and the rise in the number of chronic diseases across the region.

Segments

Segments Covered in the Report
The global wearable injectors market has been segmented on the basis of

Applications
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Oncology
  • Infectious Diseases
  • Others
Types
  • Off-body
  • On-body
Technology
  • Expanding Battery
  • Motor-driven
  • Spring-based
  • Rotary Pump
  • Others
End-users
  • Clinics
  • Home Care
  • Hospitals
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • CeQur SA
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • Unilife Corp.
  • SteadyMed Therapeutics, Inc.
  • Amgen, Inc.
  • Insulet Corp.
  • Enable Injections, Inc.
  • Johnson & Johnson Pvt. Ltd.

Competitive Landscape

Key players competing in the global wearable injectors market are CeQur SA; West Pharmaceutical Services, Inc.; Becton, Dickinson and Company; F. Hoffmann-La Roche AG; Unilife Corp.; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet Corp.; Enable Injections, Inc.; and Johnson & Johnson Pvt. Ltd. As part of their efforts to acquire a competitive advantage over competitors and expand their client base, manufacturers operating in the market have opted numerous strategic initiatives, such as collaborations, mergers & acquisitions, and partnerships. Moreover, companies are focusing on investment in R&D for launching new products and development to maintain their competitive positions in the market.

For instance, in June 2020, Insulet Corp. along with its Omnipod Insulin Management System, a global leader in tubeless insulin pump technology, expanded its financial aid program for its customers in the United States. The consumer may receive up to a six-month supply of products (60 Pods) for free as part of the program. Customers who lost their employment and insurance as a result of the pandemic and were not covered by Medicaid or other insurance were eligible for the program.

Wearable Injectors Market By key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Wearable Injectors Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Wearable Injectors Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Wearable Injectors Market - Supply Chain
  4.5. Global Wearable Injectors Market Forecast
     4.5.1. Wearable Injectors Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Wearable Injectors Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Wearable Injectors Market Absolute $ Opportunity
5. Global Wearable Injectors Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Wearable Injectors Market Size and Volume Forecast by Types
     5.3.1. Off-body On-body
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Wearable Injectors Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Wearable Injectors Market Size and Volume Forecast by Applications
     6.3.1. Cardiovascular Diseases Autoimmune Diseases Oncology Infectious Diseases Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Wearable Injectors Market Analysis and Forecast by End Users
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by End Users
     7.2.2. Y-o-Y Growth Projections by End Users
  7.3. Wearable Injectors Market Size and Volume Forecast by End Users
     7.3.1. Clinics Home Care Hospitals Others
  7.4. Absolute $ Opportunity Assessment by End Users
  7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Wearable Injectors Market Analysis and Forecast by Region
  8.1. Market Trends
  8.2. Introduction
     8.2.1. Basis Point Share (BPS) Analysis by Region
     8.2.2. Y-o-Y Growth Projections by Region
  8.3. Wearable Injectors Market Size and Volume Forecast by Region
     8.3.1. North America
     8.3.2. Latin America
     8.3.3. Europe
     8.3.4. Asia Pacific
     8.3.5. Middle East and Africa (MEA)
  8.4. Absolute $ Opportunity Assessment by Region
  8.5. Market Attractiveness/Growth Potential Analysis by Region
  8.6. Global Wearable Injectors Demand Share Forecast, 2019-2026
9. North America Wearable Injectors Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
  9.2. North America Wearable Injectors Market Size and Volume Forecast by Country
     9.2.1. U.S.
     9.2.2. Canada
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. North America Wearable Injectors Market Size and Volume Forecast by Types
     9.4.1. Off-body On-body
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. North America Wearable Injectors Market Size and Volume Forecast by Applications
     9.7.1. Cardiovascular Diseases Autoimmune Diseases Oncology Infectious Diseases Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. North America Wearable Injectors Market Size and Volume Forecast by End Users
     9.10.1. Clinics Home Care Hospitals Others
  9.11. Basis Point Share (BPS) Analysis by End Users
  9.12. Y-o-Y Growth Projections by End Users
  9.13. Market Attractiveness/Growth Potential Analysis
     9.13.1. By Country
     9.13.2. By Product Type
     9.13.3. By Application
  9.14. North America Wearable Injectors Demand Share Forecast, 2019-2026
10. Latin America Wearable Injectors Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Latin America Average Pricing Analysis
  10.2. Latin America Wearable Injectors Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
  10.4. Latin America Wearable Injectors Market Size and Volume Forecast by Types
     10.4.1. Off-body On-body
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Latin America Wearable Injectors Market Size and Volume Forecast by Applications
     10.7.1. Cardiovascular Diseases Autoimmune Diseases Oncology Infectious Diseases Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Latin America Wearable Injectors Market Size and Volume Forecast by End Users
     10.10.1. Clinics Home Care Hospitals Others
  10.11. Basis Point Share (BPS) Analysis by End Users
  10.12. Y-o-Y Growth Projections by End Users
  10.13. Market Attractiveness/Growth Potential Analysis
     10.13.1. By Country
     10.13.2. By Product Type
     10.13.3. By Application
  10.14. Latin America Wearable Injectors Demand Share Forecast, 2019-2026
11. Europe Wearable Injectors Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Europe Average Pricing Analysis
  11.2. Europe Wearable Injectors Market Size and Volume Forecast by Country
     11.2.1. Germany
     11.2.2. France
     11.2.3. Italy
     11.2.4. U.K.
     11.2.5. Spain
     11.2.6. Russia
     11.2.7. Rest of Europe
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Europe Wearable Injectors Market Size and Volume Forecast by Types
     11.4.1. Off-body On-body
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Europe Wearable Injectors Market Size and Volume Forecast by Applications
     11.7.1. Cardiovascular Diseases Autoimmune Diseases Oncology Infectious Diseases Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Europe Wearable Injectors Market Size and Volume Forecast by End Users
     11.10.1. Clinics Home Care Hospitals Others
  11.11. Basis Point Share (BPS) Analysis by End Users
  11.12. Y-o-Y Growth Projections by End Users
  11.13. Market Attractiveness/Growth Potential Analysis
     11.13.1. By Country
     11.13.2. By Product Type
     11.13.3. By Application
  11.14. Europe Wearable Injectors Demand Share Forecast, 2019-2026
12. Asia Pacific Wearable Injectors Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Asia Pacific Average Pricing Analysis
  12.2. Asia Pacific Wearable Injectors Market Size and Volume Forecast by Country
     12.2.1. China
     12.2.2. Japan
     12.2.3. South Korea
     12.2.4. India
     12.2.5. Australia
     12.2.6. Rest of Asia Pacific (APAC)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Asia Pacific Wearable Injectors Market Size and Volume Forecast by Types
     12.4.1. Off-body On-body
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Asia Pacific Wearable Injectors Market Size and Volume Forecast by Applications
     12.7.1. Cardiovascular Diseases Autoimmune Diseases Oncology Infectious Diseases Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Asia Pacific Wearable Injectors Market Size and Volume Forecast by End Users
     12.10.1. Clinics Home Care Hospitals Others
  12.11. Basis Point Share (BPS) Analysis by End Users
  12.12. Y-o-Y Growth Projections by End Users
  12.13. Market Attractiveness/Growth Potential Analysis
     12.13.1. By Country
     12.13.2. By Product Type
     12.13.3. By Application
  12.14. Asia Pacific Wearable Injectors Demand Share Forecast, 2019-2026
13. Middle East & Africa Wearable Injectors Market Analysis and Forecast
  13.1. Introduction
     13.1.1. Basis Point Share (BPS) Analysis by Country
     13.1.2. Y-o-Y Growth Projections by Country
     13.1.3. Middle East & Africa Average Pricing Analysis
  13.2. Middle East & Africa Wearable Injectors Market Size and Volume Forecast by Country
     13.2.1. Saudi Arabia
     13.2.2. South Africa
     13.2.3. UAE
     13.2.4. Rest of Middle East & Africa (MEA)
  13.3. Absolute $ Opportunity Assessment by Country
  13.4. Middle East & Africa Wearable Injectors Market Size and Volume Forecast by Types
     13.4.1. Off-body On-body
  13.5. Basis Point Share (BPS) Analysis by Types
  13.6. Y-o-Y Growth Projections by Types
  13.7. Middle East & Africa Wearable Injectors Market Size and Volume Forecast by Applications
     13.7.1. Cardiovascular Diseases Autoimmune Diseases Oncology Infectious Diseases Others
  13.8. Basis Point Share (BPS) Analysis by Applications
  13.9. Y-o-Y Growth Projections by Applications
  13.10. Middle East & Africa Wearable Injectors Market Size and Volume Forecast by End Users
     13.10.1. Clinics Home Care Hospitals Others
  13.11. Basis Point Share (BPS) Analysis by End Users
  13.12. Y-o-Y Growth Projections by End Users
  13.13. Market Attractiveness/Growth Potential Analysis
     13.13.1. By Country
     13.13.2. By Product Type
     13.13.3. By Application
  13.14. Middle East & Africa Wearable Injectors Demand Share Forecast, 2019-2026
14. Competition Landscape
  14.1. Global Wearable Injectors Market: Market Share Analysis
  14.2. Wearable Injectors Distributors and Customers
  14.3. Wearable Injectors Market: Competitive Dashboard
  14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     14.4.1. CeQur SA West Pharmaceutical Services, Inc. Becton, Dickinson and Company F. Hoffmann-La Roche AG Unilife Corp. SteadyMed Therapeutics, Inc.  
Segments Covered in the Report
The global wearable injectors market has been segmented on the basis of

Applications
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Oncology
  • Infectious Diseases
  • Others
Types
  • Off-body
  • On-body
Technology
  • Expanding Battery
  • Motor-driven
  • Spring-based
  • Rotary Pump
  • Others
End-users
  • Clinics
  • Home Care
  • Hospitals
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • CeQur SA
  • West Pharmaceutical Services, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • Unilife Corp.
  • SteadyMed Therapeutics, Inc.
  • Amgen, Inc.
  • Insulet Corp.
  • Enable Injections, Inc.
  • Johnson & Johnson Pvt. Ltd.

Key players competing in the global wearable injectors market are CeQur SA; West Pharmaceutical Services, Inc.; Becton, Dickinson and Company; F. Hoffmann-La Roche AG; Unilife Corp.; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet Corp.; Enable Injections, Inc.; and Johnson & Johnson Pvt. Ltd. As part of their efforts to acquire a competitive advantage over competitors and expand their client base, manufacturers operating in the market have opted numerous strategic initiatives, such as collaborations, mergers & acquisitions, and partnerships. Moreover, companies are focusing on investment in R&D for launching new products and development to maintain their competitive positions in the market.

For instance, in June 2020, Insulet Corp. along with its Omnipod Insulin Management System, a global leader in tubeless insulin pump technology, expanded its financial aid program for its customers in the United States. The consumer may receive up to a six-month supply of products (60 Pods) for free as part of the program. Customers who lost their employment and insurance as a result of the pandemic and were not covered by Medicaid or other insurance were eligible for the program.

Wearable Injectors Market By key players

Buy Report